A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2021-04-27
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and efficacy of two anti-cancer
drugs (gemcitabine and docetaxel) with and without the study drug known as olaratumab in
participants with advanced soft tissue sarcoma (STS) or STS that has spread to another
part(s) of the body.